login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
ALIGOS THERAPEUTICS INC (ALGS) Stock News
USA
- NASDAQ:ALGS -
US01626L2043
-
Common Stock
6.66
USD
+0.59 (+9.72%)
Last: 11/14/2025, 8:00:00 PM
6.78
USD
+0.12 (+1.8%)
After Hours:
11/14/2025, 8:00:00 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
ALGS Latest News, Press Relases and Analysis
All
Press Releases
17 hours ago - By: Aligos Therapeutics
Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
17 hours ago - By: Aligos Therapeutics
Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
5 days ago - By: Aligos Therapeutics
Aligos Therapeutics Presents Positive Data at The Liver Meeting® 2025
9 days ago - By: Aligos Therapeutics
Aligos Therapeutics Reports Recent Business Progress and Third Quarter 2025 Financial Results
9 days ago - By: Benzinga
- Mentions:
STVN
PODD
AMRK
SOLV
...
Earnings Scheduled For November 6, 2025
3 months ago - By: Benzinga
- Mentions:
OEC
VTLE
DIN
INSE
...
Earnings Scheduled For August 6, 2025
9 days ago - By: Aligos Therapeutics
Aligos Therapeutics Reports Recent Business Progress and Third Quarter 2025 Financial Results
11 days ago - By: Aligos Therapeutics
Aligos Therapeutics to Present at Upcoming Investor Conferences
11 days ago - By: Aligos Therapeutics
Aligos Therapeutics to Present at Upcoming Investor Conferences
16 days ago - By: Aligos Therapeutics
Aligos Therapeutics to Announce 3rd Quarter 2025 Financial Results on November 6, 2025
16 days ago - By: Aligos Therapeutics
Aligos Therapeutics to Announce 3rd Quarter 2025 Financial Results on November 6, 2025
a month ago - By: Aligos Therapeutics
Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
a month ago - By: Aligos Therapeutics
Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
a month ago - By: Aligos Therapeutics
Aligos Therapeutics Receives USAN Council Approval for pevifoscorvir sodium as Nonproprietary Name for ALG-000184
a month ago - By: Aligos Therapeutics
Aligos Therapeutics Receives USAN Council Approval for pevifoscorvir sodium as Nonproprietary Name for ALG-000184
a month ago - By: Aligos Therapeutics
Aligos Therapeutics to Present at the H.C. Wainwright Liver Disease Conference
a month ago - By: Aligos Therapeutics
Aligos Therapeutics to Present at the H.C. Wainwright Liver Disease Conference
a month ago - By: Aligos Therapeutics
Aligos Therapeutics Announces Eight Abstracts Accepted at The Liver Meeting® 2025
a month ago - By: Aligos Therapeutics
Aligos Therapeutics Announces Eight Abstracts Accepted at The Liver Meeting® 2025
2 months ago - By: Zacks Investment Research
Does Aligos Therapeutics (ALGS) Have the Potential to Rally 737.74% as Wall Street Analysts Expect?
2 months ago - By: Aligos Therapeutics
Aligos Therapeutics Announces Six Preclinical Presentations at the 2025 International HBV Meeting
2 months ago - By: Aligos Therapeutics
Aligos Therapeutics Announces Six Preclinical Presentations at the 2025 International HBV Meeting
2 months ago - By: Aligos Therapeutics
Aligos Therapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference
2 months ago - By: Aligos Therapeutics
Aligos Therapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference
2 months ago - By: Zacks Investment Research
- Mentions:
SNY
ADPT
AKRO
Sanofi Gets FDA Nod for Wayrilz in Immune Thrombocytopenia
3 months ago - By: Zacks Investment Research
- Mentions:
AMRN
RCKT
AKRO
RCKT Stock Rises as FDA Lifts Clinical Hold on Danon Disease Study
3 months ago - By: Aligos Therapeutics
Aligos Therapeutics Strengthens Senior Leadership Team with the Appointment of Ramón Polo as Senior Vice President, Head of Global Regulatory Affairs
3 months ago - By: Aligos Therapeutics
Aligos Therapeutics Strengthens Senior Leadership Team with the Appointment of Ramón Polo as Senior Vice President, Head of Global Regulatory Affairs
3 months ago - By: Zacks Investment Research
Wall Street Analysts Predict a 983.24% Upside in Aligos Therapeutics (ALGS): Here's What You Should Know
3 months ago - By: Aligos Therapeutics
Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
3 months ago - By: Aligos Therapeutics
Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
3 months ago - By: Zacks Investment Research
- Mentions:
ALLO
AMRN
AKRO
Allogene's Q2 Loss Narrower Than Expected, Pipeline in Focus
3 months ago - By: Aligos Therapeutics
Aligos Therapeutics Announces First Subject Dosed in the Phase 2 B-SUPREME Study of ALG-000184 in Subjects with Chronic HBV Infection
3 months ago - By: Aligos Therapeutics
Aligos Therapeutics Announces First Subject Dosed in the Phase 2 B-SUPREME Study of ALG-000184 in Subjects with Chronic HBV Infection
3 months ago - By: Zacks Investment Research
- Mentions:
RGNX
Aligos Therapeutics, Inc. (ALGS) Reports Q2 Loss, Misses Revenue Estimates
3 months ago - By: Aligos Therapeutics
Aligos Therapeutics Reports Recent Business Progress and Second Quarter 2025 Financial Results
3 months ago - By: Aligos Therapeutics
Aligos Therapeutics Reports Recent Business Progress and Second Quarter 2025 Financial Results
4 months ago - By: Aligos Therapeutics
Aligos Therapeutics to Announce 2nd Quarter 2025 Financial Results on August 6, 2025
4 months ago - By: Aligos Therapeutics
Aligos Therapeutics to Announce 2nd Quarter 2025 Financial Results on August 6, 2025
Please enable JavaScript to continue using this application.